Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidin-1-ium-4-carboxylic Acid;chloride
2. Chebi:59790
3. 1-(3-cyano-3,3-diphenylpropyl)-4-phenylisonipecotic Acid Hydrochloride
4. 4-carboxy-1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidinium Chloride
5. 1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic Acid Hydrochloride
Molecular Weight | 461.0 g/mol |
---|---|
Molecular Formula | C28H29ClN2O2 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 7 |
Exact Mass | 460.1917559 g/mol |
Monoisotopic Mass | 460.1917559 g/mol |
Topological Polar Surface Area | 65.5 Ų |
Heavy Atom Count | 33 |
Formal Charge | 0 |
Complexity | 636 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Related Excipient Companies
Excipients by Applications
ABOUT THIS PAGE
A Difenoxin Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Difenoxin Hydrochloride, including repackagers and relabelers. The FDA regulates Difenoxin Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Difenoxin Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Difenoxin Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Difenoxin Hydrochloride supplier is an individual or a company that provides Difenoxin Hydrochloride active pharmaceutical ingredient (API) or Difenoxin Hydrochloride finished formulations upon request. The Difenoxin Hydrochloride suppliers may include Difenoxin Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Difenoxin Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Difenoxin Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Difenoxin Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Difenoxin Hydrochloride DMFs exist exist since differing nations have different regulations, such as Difenoxin Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Difenoxin Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Difenoxin Hydrochloride USDMF includes data on Difenoxin Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Difenoxin Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Difenoxin Hydrochloride suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Difenoxin Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Difenoxin Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Difenoxin Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Difenoxin Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Difenoxin Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Difenoxin Hydrochloride suppliers with NDC on PharmaCompass.
Difenoxin Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Difenoxin Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Difenoxin Hydrochloride GMP manufacturer or Difenoxin Hydrochloride GMP API supplier for your needs.
A Difenoxin Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Difenoxin Hydrochloride's compliance with Difenoxin Hydrochloride specifications and serves as a tool for batch-level quality control.
Difenoxin Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Difenoxin Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Difenoxin Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Difenoxin Hydrochloride EP), Difenoxin Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Difenoxin Hydrochloride USP).
LOOKING FOR A SUPPLIER?